Sumitomo Pharma
4506
Chugai Pharmaceutical
4519
SanBio
4592
4
Nippon Telegraph & Telephone
9432
5
Metaplanet
3350
JP Stock MarketDetailed Quotes
2311 EPCO
- 695
- +10+1.46%
20min DelayMarket Closed Apr 18 15:30 JST
6.47BMarket Cap19.00P/E (Static)
703High692Low24.60KVolume692Open685Pre Close17.15MTurnover83852wk High0.61%Turnover Ratio9.32MShares63052wk Low36.58EPS TTM2.82BFloat Cap6500Historical High19.00P/E (Static)4.06MShs Float213Historical Low36.58EPS LYR1.61%Amplitude32.00Dividend TTM1.34P/B100Lot Size4.60%Div YieldTTM
EPCO Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 10.82%5.61B | 17.41%1.44B | 15.01%1.35B | 5.01%5.06B | 9.59%1.35B | 8.14%1.31B | 2.24%1.23B | -0.15%1.18B | 2.60%4.82B | 0.41%1.23B |
| Cost of revenue | 3.33%3.86B | 7.98%984.57M | 7.16%952.27M | 3.62%3.74B | 5.44%1B | 5.92%936.57M | 1.31%911.84M | 1.68%888.66M | 11.57%3.61B | 8.41%949.88M |
| Gross profit | 32.00%1.74B | 44.73%455.82M | 39.18%401.74M | 9.17%1.32B | 23.66%346.15M | 14.16%371.39M | 5.05%314.95M | -5.38%288.66M | -17.25%1.21B | -19.70%279.93M |
| Operating expense | 21.56%1.41B | 29.60%352.75M | 19.98%332.24M | 1.31%1.16B | 13.55%323.5M | -3.78%286.79M | -2.56%272.18M | -1.84%276.91M | 11.69%1.14B | 6.38%284.89M |
| Operating profit | 106.80%334.54M | 141.00%103.07M | 491.41%69.5M | 146.00%161.77M | 556.85%22.65M | 210.04%84.61M | 108.87%42.77M | -48.80%11.75M | -84.98%65.76M | -106.14%-4.96M |
| Net non-operating interest income (expenses) | 18.95%11.03M | 5.83%2.18M | -44.43%972K | 73.19%9.27M | -10.28%1.61M | 109.64%3.85M | 36.32%2.06M | 740.87%1.75M | 659.29%5.35M | 1,386.78%1.8M |
| Non-operating interest income | 19.31%13.35M | -19.07%2.79M | -32.70%1.18M | 109.10%11.19M | 18.73%2.14M | 110.29%3.86M | 128.30%3.45M | 740.87%1.75M | 659.29%5.35M | 1,386.78%1.8M |
| Non-operating interest expense | 21.02%2.33M | -55.98%611K | --205K | --1.92M | --522K | --12K | --1.39M | --0 | --0 | --0 |
| Net investment income | 54.80%-5.8M | 78.65%-2.17M | -48.25%-467K | -133.45%-12.83M | -118.03%-1.41M | -106.10%-949K | -192.40%-10.15M | -107.89%-315K | 959.81%38.34M | 1,239.07%7.81M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 10.21%280.97M | 25.79%170.8M | 0 | -59.04%254.94M | 135.78M | ||||
| Income from associates and other participating interests | -65.94%87.76M | -233.17%-31.32M | -567.14%-28.36M | 164.00%257.68M | 400.12%181.15M | 9.93%46.94M | 129.21%23.52M | -27.92%6.07M | 234.95%97.61M | 234.86%36.22M |
| Special income (charges) | -101.47%-1.02M | -131.97%-823K | -100.32%-199K | 26,006.32%69.69M | 1,606.38%1.6M | 1,514.63%2.9M | 1,688.89%2.57M | 1,565,150.00%62.61M | 89.02%-269K | 1,980.00%94K |
| Less:Other special charges | 101.47%1.02M | 131.97%823K | 100.32%199K | -26,006.32%-69.69M | -1,606.38%-1.6M | -1,514.63%-2.9M | -1,688.89%-2.57M | -1,565,150.00%-62.61M | -89.02%269K | -1,980.00%-94K |
| Other non-operating income (expenses) | 35.84%13.58M | 21,853.49%9.44M | -9.82%1.12M | 0.86%10M | 203.34%6.9M | -2.26%1.82M | -98.80%43K | -43.16%1.24M | 877.51%9.91M | 209.54%2.27M |
| Income before tax | -43.33%440.09M | -52.99%80.37M | -48.78%42.57M | 64.65%776.56M | 114.10%383.3M | 56.32%139.16M | 3.11%170.98M | 120.05%83.11M | -52.40%471.65M | -73.43%179.03M |
| Income tax | -24.70%112.98M | -20.44%38.7M | -13.02%23.93M | 33.48%150.03M | -14.84%40.93M | 65.82%32.95M | 19.85%48.64M | 607.80%27.51M | -66.22%112.4M | -74.79%48.06M |
| Net income | -47.79%327.11M | -65.94%41.67M | -66.48%18.64M | 74.40%626.53M | 161.42%342.37M | 53.59%106.22M | -2.32%122.34M | 64.10%55.6M | -45.41%359.25M | -72.89%130.97M |
| Net income continuous operations | -47.79%327.11M | -65.94%41.67M | -66.48%18.64M | 74.40%626.53M | 161.42%342.37M | 53.59%106.22M | -2.31%122.34M | 64.09%55.6M | -45.41%359.25M | -72.89%130.97M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -47.79%327.11M | -65.94%41.67M | -66.48%18.64M | 74.40%626.53M | 161.42%342.37M | 53.59%106.22M | -2.32%122.34M | 64.10%55.6M | -45.41%359.25M | -72.89%130.97M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -47.79%327.11M | -65.94%41.67M | -66.48%18.64M | 74.40%626.53M | 161.42%342.37M | 53.59%106.22M | -2.32%122.34M | 64.10%55.6M | -45.41%359.25M | -72.89%130.97M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -47.85%36.58 | -65.99%4.66 | -66.45%2.09 | 74.13%70.14 | 161.04%38.32 | 53.42%11.89 | -2.49%13.7 | 63.95%6.23 | -45.46%40.28 | -72.92%14.68 |
| Diluted earnings per share | -47.85%36.58 | -66.01%4.6573 | -66.45%2.09 | 74.13%70.14 | 161.05%38.3132 | 53.42%11.89 | -2.49%13.7 | 63.95%6.23 | -45.46%40.28 | -72.92%14.6764 |
| Dividend per share | 0.00%32 | 0.00%14 | 0 | 0.00%32 | 0.00%18 | 0 | 0.00%14 | 0 | 0.00%32 | -7.69%18 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |